Intraplaque haemorrhages as the trigger of plaque vulnerability

JB Michel, R Virmani, E Arbustini… - European heart …, 2011 - academic.oup.com
Atherothrombosis remains one of the main causes of morbidity and mortality in the western
countries. Human atherothrombotic disease begins early in life in relation to circulating lipid …

Non-coronary atherosclerosis

A Gallino, V Aboyans, C Diehm… - European heart …, 2014 - academic.oup.com
During the last decades, the clinical and research interest in atherosclerosis has been
mostly focused on coronary arteries. After the publications of the European Society …

[HTML][HTML] The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 …

PS Sidhu, V Cantisani, CF Dietrich… - Ultraschall in der …, 2018 - thieme-connect.com
Thieme E-Journals - Ultraschall in der Medizin - European Journal of Ultrasound / Full Text DE
EN Home Products Journals Books Book Series Service Library Service Help Contact Portal …

[HTML][HTML] The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications

F Piscaglia, C Nolsøe, CF Dietrich… - Ultraschall in der …, 2012 - thieme-connect.com
The first studies on the clinical use of ultrasound contrast agents (UCAs) with contrast
specific imaging techniques were published at the beginning of this century using Levovist® …

[HTML][HTML] STAT6 upregulation promotes M2 macrophage polarization to suppress atherosclerosis

M Gong, X Zhuo, A Ma - Medical science monitor basic research, 2017 - ncbi.nlm.nih.gov
Background Macrophages are highly heterogeneous and plastic cells that are involved in all
stages of atherogenesis. They can undergo polarization by shifting between M1 and M2 …

Phase-change contrast agents for imaging and therapy

PS Sheeran, PA Dayton - Current pharmaceutical design, 2012 - ingentaconnect.com
Phase-change contrast agents (PCCAs) for ultrasound-based applications have resulted in
novel ways of approaching diagnostic and therapeutic techniques beyond what is possible …

Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging

PS Sheeran, VP Wong, S Luois, RJ McFarland… - Ultrasound in medicine …, 2011 - Elsevier
Currently available microbubbles used for ultrasound imaging and therapeutics are limited
to intravascular space due to their size distribution in the micron range. Phase-change …

International Union of Angiology (IUA) consensus paper on imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced approaches

L Saba, PL Antignani, A Gupta, R Cau, KI Paraskevas… - Atherosclerosis, 2022 - Elsevier
Cardiovascular disease (CVD) is the leading cause of mortality and disability in developed
countries. According to WHO, an estimated 17.9 million people died from CVDs in 2019 …

Coronary plaque characterization using CT

F Saremi, S Achenbach - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. In this article, we review the histopathologic classification of coronary
atherosclerotic plaques and describe the possibilities and limitations of CT regarding the …

Carotid intraplaque neovascularization predicts coronary artery disease and cardiovascular events

LE Mantella, KN Colledanchise, MF Hetu… - European Heart …, 2019 - academic.oup.com
Aims It is thought that the majority of cardiovascular (CV) events are caused by vulnerable
plaque. Such lesions are rupture prone, in part due to neovascularization. It is postulated …